2-Iodo-5-trifluoromethylpyridine

Catalog No.: 
ACAMEO124
CAS No.: 
100366-75-4
Molecular Formula: 
C6H3F3IN
Molecular Weight: 
272.99
2-Iodo-5-trifluoromethylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g98%
25g98%
50g98%
100g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Iodo-5-trifluoromethylpyridine
IUPAC Name2-iodo-5-(trifluoromethyl)pyridine
MDL No.MFCD08741351
Molecular FormulaC6H3F3IN
Molecular Weight272.99
SMILESIC1=NC=C(C=C1)C(F)(F)F
InChI KeyWSEVWIIOEQZEOU-UHFFFAOYSA-N
Synonym2-Iodo-5-trifluoromethyl-pyridine, AldrichCPR | FT-0649971 | W-204368 | Pyridine, 2-iodo-5-(trifluoromethyl)- | MFCD08741351 | 2-Iodo-5-(trifluoromethyl)pyridine | AKOS005063768 | 2-iodanyl-5-(trifluoromethyl)pyridine | AC-23279 | SCHEMBL764716 | 2-iodo-5
CAS No.100366-75-4
PubChem CID22147841

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACAMEO124 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCPHV394 route compound structure diagram
    ACCPHV39450488-42-1In Stock
  2. Then
  3. ACAMEO124 route product structure diagram
    ACAMEO124100366-75-4In Stock
Inquiry

2. ACAMEO124 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGLDE876 route compound structure diagram
    ACGLDE87674784-70-6In Stock
  4. Then
  5. ACAMEO124 route product structure diagram
    ACAMEO124100366-75-4In Stock
Inquiry

3. ACAMEO124 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFRZX973 route compound structure diagram
    ACFRZX97352334-81-3
  2. Then
  3. ACAMEO124 route product structure diagram
    ACAMEO124100366-75-4In Stock
Inquiry

Comments (0)